237 related articles for article (PubMed ID: 28447433)
1. Serum vitamin D level is related to disease severity in pediatric alopecia areata.
Unal M; Gonulalan G
J Cosmet Dermatol; 2018 Feb; 17(1):101-104. PubMed ID: 28447433
[TBL] [Abstract][Full Text] [Related]
2. Correlation of vitamin D and vitamin D receptor expression in patients with alopecia areata: a clinical paradigm.
Daroach M; Narang T; Saikia UN; Sachdeva N; Sendhil Kumaran M
Int J Dermatol; 2018 Feb; 57(2):217-222. PubMed ID: 29243839
[TBL] [Abstract][Full Text] [Related]
3. Study on Serum Vitamin D in Alopecia Areata Patients.
Marahatta S; Agrawal S; Khan S
J Nepal Health Res Counc; 2019 Apr; 17(1):21-25. PubMed ID: 31110371
[TBL] [Abstract][Full Text] [Related]
4. Association between vitamin D levels and alopecia areata.
Mahamid M; Abu-Elhija O; Samamra M; Mahamid A; Nseir W
Isr Med Assoc J; 2014 Jun; 16(6):367-70. PubMed ID: 25058999
[TBL] [Abstract][Full Text] [Related]
5. An investigation of vitamin D status in alopecia areata.
Gade VKV; Mony A; Munisamy M; Chandrashekar L; Rajappa M
Clin Exp Med; 2018 Nov; 18(4):577-584. PubMed ID: 29869122
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D deficiency in alopecia areata.
Aksu Cerman A; Sarikaya Solak S; Kivanc Altunay I
Br J Dermatol; 2014 Jun; 170(6):1299-304. PubMed ID: 24655364
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D Deficiency in Alopecia Areata.
Ghafoor R; Anwar MI
J Coll Physicians Surg Pak; 2017 Apr; 27(4):200-202. PubMed ID: 28492146
[TBL] [Abstract][Full Text] [Related]
8. Increased prevalence of vitamin D deficiency in patients with alopecia areata: a systematic review and meta-analysis.
Lee S; Kim BJ; Lee CH; Lee WS
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1214-1221. PubMed ID: 29633370
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D Level in Alopecia Areata.
Bhat YJ; Latif I; Malik R; Hassan I; Sheikh G; Lone KS; Majeed S; Sajad P
Indian J Dermatol; 2017; 62(4):407-410. PubMed ID: 28794553
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of topical calcipotriol in management of alopecia areata: A pilot study.
Narang T; Daroach M; Kumaran MS
Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28133875
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein as a novel biomarker for vitamin D deficiency in alopecia areata.
AbdElneam AI; Al-Dhubaibi MS; Bahaj SS; Mohammed GF; Alantry AK; Atef LM
Skin Res Technol; 2024 Mar; 30(3):e13657. PubMed ID: 38528743
[TBL] [Abstract][Full Text] [Related]
12. Serum level of interleukin-17A in patients with alopecia areata and its relationship to age.
El-Morsy EH; Eid AA; Ghoneim H; Al-Tameemi KA
Int J Dermatol; 2016 Aug; 55(8):869-74. PubMed ID: 26475394
[TBL] [Abstract][Full Text] [Related]
13. Correlation between serum IL-17A level and SALT score in patients with alopecia areata before and after NB-UVB therapy.
Morsy H; Maher R; Negm D
J Cosmet Dermatol; 2018 Jun; 17(3):533-537. PubMed ID: 29707896
[TBL] [Abstract][Full Text] [Related]
14. Assessment of vitamin D receptors in alopecia areata and androgenetic alopecia.
Fawzi MM; Mahmoud SB; Ahmed SF; Shaker OG
J Cosmet Dermatol; 2016 Dec; 15(4):318-323. PubMed ID: 27151518
[TBL] [Abstract][Full Text] [Related]
15. Elucidating the role of T-Reg related cytokines: serum transforming growth factor beta and interleukin-35 in alopecia areata.
Yuksek T; Gonul M; Kartal SP; Gungor EB; Hatil SI
Arch Dermatol Res; 2024 May; 316(6):205. PubMed ID: 38787409
[TBL] [Abstract][Full Text] [Related]
16. Estimated serum vitamin D status, vitamin D intake, and risk of incident alopecia areata among US women.
Thompson JM; Li T; Park MK; Qureshi AA; Cho E
Arch Dermatol Res; 2016 Nov; 308(9):671-676. PubMed ID: 27664090
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of serum zinc level in patients with newly diagnosed and resistant alopecia areata.
Abdel Fattah NS; Atef MM; Al-Qaradaghi SM
Int J Dermatol; 2016 Jan; 55(1):24-9. PubMed ID: 26147750
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum tumour necrosis factor-like weak inducer of apoptosis in alopecia areata: a possible marker of disease severity.
Sayed K; Mohammed F; Abdel Hay R; Ezzeldin N; Rashed L; Fahim A
Clin Exp Dermatol; 2020 Jun; 45(4):426-431. PubMed ID: 31587331
[TBL] [Abstract][Full Text] [Related]
19. Serum level of macrophage migration inhibitory factor (MIF) in Egyptians with alopecia areata and its relation to the clinical severity of the disease.
Younan DN; Agamia N; Elshafei A; Ebeid N
J Clin Lab Anal; 2015 Jan; 29(1):74-9. PubMed ID: 24687398
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin as a novel biomarker of disease severity in alopecia areata.
Stochmal A; Waśkiel-Burnat A; Chrostowska S; Zaremba M; Rakowska A; Czuwara J; Rudnicka L
Sci Rep; 2021 Jul; 11(1):13809. PubMed ID: 34226603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
